Bismuth Subcitrate Potassium; Metronidazole; Tetracycline Hydrochloride Patent Expiration
Bismuth Subcitrate Potassium; Metronidazole; Tetracycline Hydrochloride is Used for treating patients with H. pylori infection and duodenal ulcer disease. It was first introduced by Laboratoires Juvise Pharmaceuticals
Bismuth Subcitrate Potassium; Metronidazole; Tetracycline Hydrochloride Patents
Given below is the list of patents protecting Bismuth Subcitrate Potassium; Metronidazole; Tetracycline Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Pylera | US6350468 | Double capsule for the administration of active principles in multiple therapies |
Dec 14, 2018
(Expired) | Labs Juvise |
Bismuth Subcitrate Potassium; Metronidazole; Tetracycline Hydrochloride's Family Patents
Explore Our Curated Drug Screens
Bismuth Subcitrate Potassium; Metronidazole; Tetracycline Hydrochloride Generic API Manufacturers
Several generic applications have been filed for Bismuth Subcitrate Potassium; Metronidazole; Tetracycline Hydrochloride. The first generic version for Bismuth Subcitrate Potassium; Metronidazole; Tetracycline Hydrochloride was by Endo Operations Ltd and was approved on Mar 6, 2023. And the latest generic version is by Novast Laboratories Ltd and was approved on Jul 3, 2023.
Given below is the list of companies who have filed for Bismuth Subcitrate Potassium; Metronidazole; Tetracycline Hydrochloride generic, along with the locations of their manufacturing plants worldwide.
1. ENDO OPERATIONS
Endo Operations Ltd has filed for 1 generic for Bismuth Subcitrate Potassium; Metronidazole; Tetracycline Hydrochloride. This 140mg;125mg;125mg version comes by the name BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE. Given below are the details of the strengths of this generic introduced by Endo Operations.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 140MG; 125MG; 125MG | capsule | Prescription | ORAL | AB | Mar 6, 2023 |
2. NOVAST LABS
Novast Laboratories Ltd has filed for 1 generic for Bismuth Subcitrate Potassium; Metronidazole; Tetracycline Hydrochloride. This 140mg;125mg;125mg version comes by the name BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE. Given below are the details of the strengths of this generic introduced by Novast Labs.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 140MG; 125MG; 125MG | capsule | Prescription | ORAL | AB | Jul 3, 2023 |